26. Mär 2024 News Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors
14. Mär 2024 News Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
6. Feb 2024 News Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001